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Self-delivery of N-hydroxylethyl Peptide Assemblies to the Cytosol 
Inducing Cancer Cell Endoplasmic Reticulum Dilation  
Shijin Zhang,a Xunwu Hu,a Dingze Mang,a Toshio Sasaki b and Ye Zhang*a 
Inspired by clinical studies on alcohol abuse induced endoplasmic 
reticulum disruption, we designed N-hydroxylethyl peptide 
assembly to regulate ER stress response in cancer cell. Coupling 
with coumarin derivative via ester link, a prodrug was synthesized 
to promote esterase-facilitated self-delivery of N-hydroxylethyl 
peptide assemblies around ER inducing ER dilation. Following that, 
ER-specific apoptosis was effectively and efficiently activated in 
various types of cancer cells including the drug resistant and 
metastatic ones. 
Endoplasmic reticulum (ER) is an elaborate network 
membrane that extends throughout the cell. Via membrane 
contacts, ER communicates with mitochondria, Golgi, 
endosomes, peroxisomes, lipid droplets, and the plasma 
membrane (PM) for coordination activities which is essential 
for cell homeostasis.1 Although the underlying mechanism is 
still elusive, the importance of ER in the control of cell fate 
makes it one of the major targets for therapeutic research. At 
present, several natural products have shown potentials in 
regulating ER stress in various cancer cell lines by targeting key 
proteins of signaling pathways.2 To improve therapeutic 
efficiency, more investigation and preclinical feedbacks to 
modify the molecular approach is highly demanded. 
In clinical studies, elevated ER stress is commonly detected in 
alcoholic patients. The ER stress following chronic alcohol 
abuse contributes to damage and dysfunction in liver, 
pancreas, heart, and brain. For example, ER dilation occurs in 
hepatocytes of alcoholics which is associated with alcoholic 
liver disease.3 Despite all the health risks, scientists made an 
interesting discovery that under the treatment of alcohol, the 
unfolded protein response (UPR) could be activated in cancer 
cells causing ER stress induced cell death.4 Although the 
underlying mechanism of alcohol abuse induced ER stress in 
cancer cell is not clear yet, the phenomenon itself is 
interesting, and it inspires us to create a prodrug approach to 
deliver alcohol derivatives reaching ER for stress regulation in 
cancer treatment. 
To create an environment of massive accumulation of alcohol 
derivatives around the ER as the mimic of 'acute alcohol abuse' 
in cancerous cell, we designed and synthesized a N-
hydroxylethyl peptide for cytosolic self-assembly. To achieve 
efficient intracellular absorption, a prodrug designed to 
promote the self-delivery5 mediated by carboxylesterase 
(CES)6-9 was introduced (Figure 1). 
 
Figure 1. Schematic illustration of N-hydroxylethyl peptide 1a assembly induced ER 
dilation, and the prodrug design to promote 1a intracellular absorption via CES-
catalyzed hydrolysis. 
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To minimize the structure modification induced functional 
alterations, we selected a super small molecular hydrogelator, 
Naphthalene-Phe-Phe,10 as the self-assembly building block to 
couple with ethanolamine for the alcohol derivative 1a. The 
hydroxyl group of 1a was protected by fluorescent coumarin 
derivative b via an ester link to obtain the prodrug 1. To prove 
that the design is rational and practical, two molecules 2 and 3 
were synthesized and characterized in comparison to 1 
(Scheme 1). Under the treatment of CES, 1 was hydrolyzed to 
1a and b (Figure S1, S2a-c), 2 was hydrolyzed to 2a and b 
(Figure S1, S2d-f). Without ester linkers, molecule 3 couldn’t 










Scheme 1. CES-catalyzed hydrolysis of 2 and 3. Reaction conditions: borate buffer, pH = 
8.0, 37 oC. 
The lipophilicity of a molecule (lipid-water partition coefficient 
logP) is a crucial factor governing passive diffusion. Therefore, 
we characterized logPoct/wat of all three molecules by testing 
their distribution in a two-phase octanol/water system (Figure 
S3), and the results were summarized in Figure 2A. Considering 
the logPoct/wat that results in the maximum rate of diffusional 
transport through biological membranes generally has a value 
of about 2,11, 12 1 and 3 are close to optimal lipophilicity 
compare with molecule 2. Since molecules 1, 2 and 3 all self-
assemble over certain concentrations, we evaluate their ability 
of self-assembly using transmission electron microscopy 
(TEM). By comparing the critical concentrations for self-
assembly and for forming stabilized nanostructures (Figure S4), 
we found that the order of self-assembly ability was 3 > 2 > 1. 
In borate solution of 1 (125 μM), the addition of CES induced 
transition of self-assembled structure from sparse aggregates 
to uniformed nanofibers (Figure 2B). For the borate solution of 
2, CES disassembled dense nanovesicles into scattered 
aggregates (Figure 2C). Self-assembled dense nanofibers of 3 
was intact after the addition of CES (Figure 2D). Apparently, 1 
is a promising prodrug candidate with relatively optimal 
lipophilicity and CES-hydrolysis-enhanced assembly leading to 
stabilized cytosolic drug accumulation. 
At various concentrations, the circular dichroism (CD) spectra 
of 1a/b or 2a/b mixture were different from the simple sums 
of their individual CD spectra (Figure 2E and Figure S5) 
suggesting that hydrolyzed components 1a and b, or 2a and b 
would co-assemble in cytosol resulting into fluorescent 
nanostructures (Figure 2F).13 Under the confocal microscope, 
HeLa cells cultured with 1 or 2, co-stained on plasma 
membrane using CellMask green showed strong fluorescence 
solely in cytosol implying efficient cell penetrations (Figure 2G, 
2H and S6). 3 was hardly absorbed by HeLa cells, instead, 
molecular assemblies were observed outside of cells attached 
to the culture dish (Figure 2I). The enzyme-catalyzed hydrolysis 
of 1 and 2 in HeLa cell lysate and extracellular culture medium 
indicated that the hydrolysis only occurred inside HeLa cells 
(Figure 2J). Therefore, we evaluated molecular absorption 
efficiency by quantifying the remaining molecules in 
extracellular culture medium of cultured HeLa cells under the 
treatment of molecules at low concentration for short period 
without causing cell death induced release of molecules. 
Figure 2K indicated that 1 and 2 had more than seven times 
higher absorption rate than 1a and 2a implicating the prodrug 
design effectively promoted the cell absorption. 
 
Figure 2. (A) A table of lipid-water partition coefficients of molecules 1, 2 and 3. TEM 
images of molecule 1 (B), 2 (C) in borate butter at a concentration of 125 μM before 
(left) and after (right) the CES-catalyzed hydrolysis. The scale bars represent 100 nm. 
(D) TEM image of molecule 3 (125 μM) in borate buffer. (E) CD spectra of 1a/b (1:1) 
mixtures (left) and 2a/b (1:1) mixtures (right) at various concentrations. Exp. and Calc. 
represent experimental and theoretically calculated CD spectra, respectively. (F) 
Schematic illustration of molecular co-assembly between 1a and b or between 2a and 
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of 10 μM for 4 hours and stained with CellMask Green (plasma membrane). Violet 
represents the emissions of coumarin derivatives. The scale bar represents 20 μm. (J) 
Kinetic profiles of CES-catalyzed hydrolysis of 1 or 2 in HeLa cell lysate or extracellular 
culture medium (isolated from cultured cells) at 37 °C. (K) Relative percentage of 1, 1a, 
2, or 2a remained in extracellular culture medium during the first 6-hour HeLa cell 
incubation under the treatment of those molecules at concentration of 10 μM. 
 
Figure 3. HeLa cell viability under the treatment of 1a and 1a/b mixture (1:1) (A), 2a or 
2a/b mixture (1:1) (B), b (C), 1 (D), and 2 (E) at various concentrations.  
HeLa cell viability results indicated that 1a was toxic (Figure 
3A), while 2a was biocompatible (Figure 3B) at various 
concentrations. Apparently, the structure modification of 
alcohol molecule into 1a successfully maintained the toxicity. 
The protection building block b barely showed toxicity on HeLa 
cells (Figure 3C). As a combination of effects from individual 
components, the 1a/b mixture showed slightly higher toxicity 
than 1a (Figure 3A), while 2a/b mixture diluted the toxicity of b 
causing biocompatibility (Figure 3B). The results suggested that 
co-assembly with b didn’t affect the overall toxicity of 1a and 
2a.  Compare with 1a and 2a, 1 exhibited the highest toxicity 
on HeLa cells (Figure 3D) and molecule 2, in contrast, was 
biocompatible (Figure 3E) implying the success of prodrug 
design by promoting the cell uptake without affecting the 
cytotoxicity of 1a and 2a. 
High-resolution confocal imaging showed that following the 
treatment of 1, 1a/b co-assemblies occupied HeLa cell cytosol 
surrounding ER and mitochondria without obvious co-
localization implicating possible close contacts (Figure 4A). 
Compare with the rough ER in untreated HeLa cells (Figure 4B), 
molecule 1 caused severe ER dilation (Figure 4C).14 Molecule 2, 
in contrast, did not cause ER dilation (Figure 4D). The structure 
of mitochondria was not affected by the treatment of 1 or 2. 
To elucidate the correlation between molecule 1 induced ER 
abnormality and HeLa cell death, we evaluated the time-
dependent apoptosis activation under the treatment of 1 by 
western blotting (Figure 4E). The expression of cleaved 
Caspase-9 showed no obvious changes during the first 12-hour 
incubation. Only after 24-hour treatment, with low HeLa cell 
viability (Figure 3D), it increased to 3 times higher than the 
control implicating that the apoptosis was not directly 
triggered by mitochondria disruption or dysfunction (Figure 
4F),15 which is consistent with their intact morphology in TEM 
images (Figure 4C). The expression of cleaved Caspase-12 
dramatically increased over time (Figure 4G) confirming ER-
specific apoptosis was activated.16 Besides structural 
disruption, accumulation of unfolded proteins also results in 
ER stress.17 Following the persistent ER stress, opposing UPR 
signals converge on DR 5 and engage the apoptosis via 
Caspase-8.18 Neither the expression of DR 5 (Figure 4H) nor 
cleaved Caspase-8 (Figure 4I) showed obvious increment. 
Therefore, under the treatment of 1, the ER-specific apoptosis 
was mainly induced by ER structure disruption−ER dilation. 
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Figure 4. (A) Fluorescence HeLa cell images after incubating with 1 (10 μM) for 4 hours 
and co-stained with ER-Red, Mito-Green. Blue represents the emissions of molecule 1’s 
derivatives.  TEM images of HeLa cell without treatment (B), under the treatment of 1 
(C) or under the treatment of 2 (D). The ER was marked by yellow arrowhead. The 
mitochondria were marked by pink arrowheads. (E) Western blotting for Caspase-12, 
DR 5, Caspase-8, and Caspase-9 expressed in HeLa cells under the treatment of 1 (20 
μM). β actin is the loading control. Time-dependent relative expression profiles of cl. 
Caspase-9 (F), cl. Caspase-12 (G), DR 5 (H), and cl. Caspase-8 (I). Results are means ± 
S.D. of three independent experiments. 
Various cancer cell lines including ovarian cancer (SKOV3 and 
drug resistant OVCAR-3), liver cancer (HepG2), and metastatic 
pancreatic cancer (PANC-1) were applied to evaluate the 
anticancer efficacy of the prodrug 1. The cell viability results 
clearly implicated anticancer effect (Figure 5). One-day 
treatment of 1 at 12.5 μM concentration killed more than 40% 
of all four types of cancer cells. Using 12.5, 25, 50, and 200 μM 
of 1, around 90% of SKOV3, OVCAR-3, HepG2 and PANC-1 cells 
were killed in two days, respectively. 
 
Figure 5. SKOV-3, OVCAR-3, HepG2 and PANC-1 cell viability under the treatment of 1 
at various concentrations. 
Conclusions 
Clinical studies on alcohol abuse induced ER stress provided 
the fundamental information that stimulated the design of N-
hydroxylethyl peptide 1a for cancer treatment via intracellular 
molecular-assembly inducing accumulation of alcohol 
derivatives as a mimic of ‘acute alcohol abuse’-like condition of 
ER. Facilitated by CES, prodrug 1 promotes self-delivery of 1a 
and activated ER-specific apoptosis efficiently. Besides the 
development of potential anticancer drug and prodrug, the 
study of synthetic molecular assembly induced ER dilation will 
contribute to studies on specific importance of the ER stress 
response in cancer cells and thus provides promising strategies 
for ER-targeted therapeutic applications. 
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